发明名称 Pyrazolopyridines and pyrazolopyridazines as antidiabetics
摘要 The present invention includes compound of formula (I), or a derivative thereof, wherein Y is CH or N; R<SUP>1 </SUP>is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl, aralkyl wherein the aryl and the alkyl moieties may each independently be unsubstituted or substituted, aralkenyl wherein the aryl, and alkenyl moieties may each independently be unsubstituted or substituted, unsubstituted or substituted heterocyclyl, or heterocyclylalkyl wherein the heterocyclyl and the alkyl moieties may each independently be unsubstituted or substituted; and R<SUP>2 </SUP>is unsubstituted aryl or unsubstituted or substituted or substituted heteroaryl. Additionally the present invention includes a process for preparing such a compound, a pharmaceutical composition containing such a compound, and the use of such a compound in medicine.
申请公布号 AU8789801(A) 申请公布日期 2002.04.02
申请号 AU20010087898 申请日期 2001.09.19
申请人 SMITHKLINE BEECHAM PLC;STEPHEN GARLAND 发明人 STEPHEN GARLAND;DAVID HAIGH;DEIRDE MARY BERNADETTE HICKEY;JOHN LIDDLE;DAVID GLYNN SMITH;JASON WITHERINGTON;ROBERT WILLIAM WARD
分类号 A61K31/437;A61K31/5025;A61P3/04;A61P3/10;A61P7/00;A61P9/10;A61P9/12;A61P15/08;A61P17/14;A61P21/04;A61P25/16;A61P25/24;A61P25/28;A61P31/04;A61P31/18;A61P35/00;A61P37/00;A61P43/00;C07D213/85;C07D471/04;C07D487/04 主分类号 A61K31/437
代理机构 代理人
主权项
地址